Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell, Marginal Zone

Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.

647 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell, Marginal Zone trial results

Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

NCT05544019

Conditions
ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
Locations
  • Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States
  • Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States
  • Napa Research Pompano Beach, Florida, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 36 locations
View Trial Details
Recruiting

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

NCT04669171

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Rochester Medical Center (URMC) - Wilmot Cancer Institute (WCI) (James P. Wilmot Cancer Center) Rochester, New York, United States
  • University of Washington-Seattle Cancer Care Alliance Seattle, Washington, United States
View Trial Details
Recruiting

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

NCT04223765

Conditions
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
Locations
  • Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

NCT05602363

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +34 more
Locations
  • UC Irvine Health Orange, California, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
View all 13 locations
View Trial Details

Related conditions